ChromaDex (CDXC) Misses Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Pre-Open Stock Movers 03/10: (MNOV) (KOSS) (CDXC) Higher; (TUP) (AVID) (JNCE) Lower (more...)
March 10, 2021 9:29 AM ESTToday's Pre-Open Stock Movers:
MediciNova, Inc. (NASDAQ: MNOV) 77.6% HIGHER; announced it has partnered with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, to repurpose MN-166 (ibudilast) as a potential medical countermeasure (MCM) against chlorine gas-induced lung damage such as acute respiratory distress syndrome (ARDS) and acute lung injury (ALI). Under the Division of Research, Innovation, and Ventures (DRIVe) Repurposing Drugs in Response to Chemical Threats (ReDIRECT)... More
ChromaDex (CDXC) Announces Retail Distribution of Tru Niagen in Walmart Stores Across the United States
March 10, 2021 6:36 AM ESTChromaDex Corp. (NASDAQ: CDXC) announced today its flagship consumer product and industry-leading NAD+ booster Tru Niagen® will be available in 3,000 Walmart retail stores across the United States beginning June 2021. ChromaDex will introduce Tru Niagen® in two packaging options for Walmart customers, which will have distinct serving sizes and price points. In addition to in-store availability, these two options will be... More
ChromaDex (CDXC) PT Raised to $18 at B.Riley
March 9, 2021 8:27 AM ESTB.Riley analyst Jeff Van Sinderen raised the price target on ChromaDex (NASDAQ: CDXC) to $18.00 (from $7.00) while maintaining a Buy rating.... More
